Clinical Trial: An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Metastatic Hormone-sensitive Prostate Cancer
Study Type: OBSERVATIONAL
Official Title: Retrospective Observational Study With Nubeqa® (Darolutamide) for the Treatment of Adult Men With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Combination With ADT and Docetaxel in BELGIUM
Brief Summary:
This is an observational study in which only observations from routine clinical practices will be made.Participants will not receive any advice on treatment or any changes to healthcare as a part of the study.In this study, medical records data of Belgian men with metastatic hormone sensitive prostate cancer (mHSPC) who had received or are receiving treatment with darolutamide in combination with androgen deprivation therapy (ADT) and docetaxel will be studied.mHSPC is a cancer of the prostate gland, a male…
Read more